Mixed lineage kinase activity of indolocarbazole analogues
- 1 January 2002
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (2), 147-150
- https://doi.org/10.1016/s0960-894x(01)00690-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- CEP‐1347/KT‐7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ‐induced cortical neuron apoptosisJournal of Neurochemistry, 2001
- CEP-1347 (KT7515), a Semisynthetic Inhibitor of the Mixed Lineage Kinase FamilyPublished by Elsevier ,2001
- JNK and p38 stresskinases — degenerative effectors of signal-transduction-cascades in the nervous systemProgress in Neurobiology, 2000
- CEP‐1347 (KT7515), an Inhibitor of JNK Activation, Rescues Sympathetic Neurons and Neuronally Differentiated PC12 Cells from Death Evoked by three Distinct InsultsJournal of Neurochemistry, 1999
- MAP kinase pathwaysProgress in Biophysics and Molecular Biology, 1999
- Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a DerivativesJournal of Medicinal Chemistry, 1997
- MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls: upstream regulators of the c-Jun amino-terminal kinases?Current Opinion in Genetics & Development, 1997
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptationsin vivoCellular and Molecular Neurobiology, 1994
- K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinasesBiochemical and Biophysical Research Communications, 1986